Patent · US Active

ApoM-Fc fusion proteins for treating lung diseases

US12415847B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignee

Children's Medical Center Corporation · US

Inventors

Timothy Hla · Wellesley, US
Steven L. Swendeman · Cambridge, US
Mark Puder · Medfield, US
Lois Smith · Newton, US

Key dates

Filing date	Oct 11, 2019
Grant date	Sep 16, 2025
Priority date	—
Expiry date	Dec 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of treating lung disease using fusion proteins comprising ApoM (e.g., human or murine ApoM) fused to a constant region (Fc) of a immunoglobulin G (IgG, e.g., human IgG or murine IgG).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.